These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20077882)

  • 1. [Gemifloxacin for the treatment of uncomplicated urinary infections (acute cystitis)].
    Blondeau JM; Tillotson GS
    Ginecol Obstet Mex; 2009 Dec; 77(12):573-82. PubMed ID: 20077882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
    Yoo BK; Triller DM; Yong CS; Lodise TP
    Ann Pharmacother; 2004; 38(7-8):1226-35. PubMed ID: 15187209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of gemifloxacin in the management of community-acquired lower respiratory tract infections.
    Blondeau JM; Tillotson G
    Int J Antimicrob Agents; 2008 Apr; 31(4):299-306. PubMed ID: 18276120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemifloxacin: a new, potent fluoroquinolone for the therapy of lower respiratory tract infections.
    File TM; Tillotson GS
    Expert Rev Anti Infect Ther; 2004 Dec; 2(6):831-43. PubMed ID: 15566328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of gemifloxacin in community-acquired pneumonia.
    Tillotson GS
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):405-18. PubMed ID: 18662107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008).
    Matsumoto T; Hamasuna R; Ishikawa K; Takahashi S; Yasuda M; Hayami H; Tanaka K; Kiyota H; Muratani T; Monden K; Arakawa S; Yamamoto S
    Int J Antimicrob Agents; 2011 Mar; 37(3):210-8. PubMed ID: 21242062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis.
    Gupta K; Hooton TM; Stamm WE
    J Antimicrob Chemother; 2005 Jul; 56(1):243-6. PubMed ID: 15911548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
    Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemifloxacin.
    Lowe MN; Lamb HM
    Drugs; 2000 May; 59(5):1137-47; discussion 1148. PubMed ID: 10852645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of urinary tract infections in the outpatient setting: a review.
    Grigoryan L; Trautner BW; Gupta K
    JAMA; 2014 Oct 22-29; 312(16):1677-84. PubMed ID: 25335150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geminofloxacin for the management of community-acquired respiratory tract infections.
    Blondeau JM; Tillotson G; Deangelis J
    J Chemother; 2006 Dec; 18(6):582-8. PubMed ID: 17267335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for acute uncomplicated cystitis in adults.
    Naber KG
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():23-7; discussion 63-5. PubMed ID: 11051620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion and bactericidal activities of gemifloxacin and ofloxacin after a single oral dose in healthy volunteers.
    Naber CK; Hammer M; Kinzig-Schippers M; Sauber C; Sörgel F; Bygate EA; Fairless AJ; Machka K; Naber KG
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3524-30. PubMed ID: 11709334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term therapy of acute uncomplicated cystitis.
    Naber KG
    Curr Opin Urol; 1999 Jan; 9(1):57-64. PubMed ID: 10726073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Norfloxacine efficacy in acute cystitis in the region with 10% resistance of E. coli to fluoroquinolones: a comparative randomized study].
    Rafal'skiĭ VV; Malev IV; Derevitskiĭ AV; Kozlov SN; Galkin VV
    Urologiia; 2009; (3):18-21. PubMed ID: 19670810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-day prulifloxacin treatment of acute uncomplicated cystitis in women with recurrent urinary tract infections: a prospective, open-label, pilot trial with 6-month follow-up.
    Cai T; Mazzoli S; Nesi G; Boddi V; Mondaini N; Bartoletti R
    J Chemother; 2009 Nov; 21(5):535-41. PubMed ID: 19933045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
    Ball P; Mandell L; Patou G; Dankner W; Tillotson G
    Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials.
    Zhang L; Wang R; Falagas ME; Chen LA; Liu YN
    Chin Med J (Engl); 2012 Feb; 125(4):687-95. PubMed ID: 22490497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The devil is in the details: observational study finds better outcomes for uncomplicated cystitis treated with fluoroquinolones.
    Grigoryan L; Salemi JL; Trautner BW
    Clin Microbiol Infect; 2020 May; 26(5):533-535. PubMed ID: 31968271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.